Geron ACTC and AAPL all up

Geron closed up 3 cents at $1.71 on 702,717 shares. Three month avg. volume is 727,414 shares. Waiting on the patent lawsuit to be settled, should be soon. Waiting for a stem cell deal. Waiting for Dec. 2012 four Phase 2 trial results.

ACTC closed up a little at 0.062 on 5 million shares. The three month avg. volume is 4.8 million shares. Same thing waiting, SEC lawsuit, partner, Phase 1/2 results.

AAPL up big $14.95 to closed at $584 on 15 million shares. The three month avg. volume is 19.7 million shares. Earnings out 7/16/2012, should tell the tale, if good we ride the wave higher, if a miss it's all over now baby blue.

Good luck in this rigged casino,

Geron, ACTC, AAPL all down

Geron closed down 8 cents at $1.68 on 856,390 shares. The three month avg, volume is 717,212. I think good news will be coming soon. No proof just a feeling. Dec 2012 we will be rich or broke when the 4 Phase 2 trial results are in.

ACTC  was down a little closed at 0.0613 on 4.3 million shares. The three month avg. volume is 4.8 million shares. Holding 6 cents, need good news or we'll break down to 5 cents.

AAPL down $5.45 at $569.05 on 10.1 million shares. The three month avg. volume is 20 million shares. Next quarter's earning will tell the tale. If good,we are past the bottom, if bad we will go down fast and hard.

Good luck in this rigged casino,

Why Geron was up Wed.

Here's why Geron was up Wed..
Sienna (Geron owns a lot) has updated its website and now the telemerase test is going to attempt to replace the PSA test. http://www.siennadiagnostics.com.au

That's good news, if it works that will be great news.

Good luck in this rigged casino,

Geron up 8% on good volume

Geron closed up 14 cents to closed at $1.76 on 1,138,256 shares. The three month avg. is 707,645 shares. This is good up higher then the last big move up on Friday. Volume still to low, but maybe, just maybe something good is coming.

ACTC closed up just a little at 0.062 on 5.2 million shares. The three month avg. volume is 4.8 million shares. Still a waiting game.

AAPL closed up $2.47 at $574.50 on 7.2 million shares. The three month avg. volume is 20.2 million shares.

Good luck in this rigged casino,

Geron and ACTC no news

Geron closed unchanged at $1.62 on only 496,400 shares. The three month avg. volume 707,645 shares. Just waiting for some kind of good news. A stem cell deal, a partner, a good Phase 2 trial results, some thing please.

ACTC, I  is said it would go lower, with no news and it will break 6 cents and hopefully hold 5 cents before the reverse split. Need good news badly very badly. Closed at 0.0611 on 7.3 million shares. The three month avg. volume is 4.8 million shares.

AAPL closed up $1.26 aat $572.03 on 9.9 million shares. The three month avg. volume is 20.2 million shares. We well see if the lower gas price will help AAPL sales.

Good luck in this rigged casino,

Geron no follow through

Geron closed down 9 cents at $1.62 on 828,532 shares. The three month avg. volume is 710,945 shares. Was hoping for follow through, but I guess we wait, for the patent settlement, the stem cell deal, results from the 4 Phase 2 trials, and a partner with lots of money for the Phase 3 trials if the Phase 2 trials are good.

ACTC down again at 0.0625 on 8.8 million shares. The three month avg. volume is 4.8 million shares. I think we go lower under 6 cents.

AAPL closed down $11.33 at $570.77 on 10.9 million shares. The three month avg. volume is 20.4 million shares. Still the best company out there.

hESC to be sold for $300 million

That's the rumor. I  hope it's right. I'm guessing it will be less money up front [maybe $100 million] and more money if it works later down the road. It's all a guess. But I like the price move up on 4+ million shares. If we can get more on Monday, just maybe something good is up. Below is some of the the rumor on Yahoo message broad.

I believe there is substantial interest in hESC's from USA, Swiss and Chinesse companies. Properly, GERN is focusing on cancer treatments now, but their eventual gain from hESC's could be much greater than $300 million. The speculation is great, and the outcome may be a pleasant surprise on several fronts.

Cancer is Geron's main interest now, but there is still behind the scenes collaboration with GE, and discussions with other companies. GE has the deep pockets that GERN needs. I believe the agreement extends to cancer research, but hESC's are still in the picture. This stock is a speculation, with many "irons in the fire".

---------------------------------------------
Part of GE agreement:

"Under the agreement between GE and Geron, Geron will provide the hESCs to GE who will develop and commercialize lab equipment that facilitates the use of the hESCs in drug development and toxicity screening. The lab equipment will then be marketed to pharmaceutical companies and research labs. According to Konstantin Fiedler, general manager of cell technologies at GE’s Healthcare division, the market for toxicity testing is expected to be in the hundreds of millions of dollars by 2020, from which Geron will begin receiving royalties by 2010.

Scientists from both companies will collaborate in the venture, with GE Healthcare providing all R&D funding. According to David Earp, senior vice president for business development and chief patents counsel at Geron, "We had an asset that we were not able to exploit fully." According to Konstantin Fiedler, general manager of cell technologies at GE Healthcare, "This agreement marks a further step in GE Healthcare’s cell technology strategy aimed at addressing the potential of stem cell applications in the drug discovery and therapy markets."

      

Geron up 16% on 4 million shares

Wow! Geron closed up 16.75% at $1.71 on a whopping 4.3 million shares. The three month avg. is only 646,853 shares.  Some say it's the Russell Index effect. Geron was added to the Russell Mirco Index. We will see Monday if we go up more on 2 million + shares then maybe something big is happening.

ACTC went down like I said it would, closed at 0.0646 on 5.9 million shares. The three month avg. volume is 4.8 million shares. It's just wait and see what happens.

AAPL closed up $4.43 at $587.10 on 10 million shares. The three month avg. is 20.7 million shares.

Good luck in this rigged casino,

Geron up while the Market went down big time

Geron closed up just a little at $1.465 on 433,818 shares. The three month avg. volume is 647,059. It's a good sign Geron didn't sell off with the over all Market. Hopefully that means good news is coming. Or at very least only the true believers own the stock.

ACTC closed down a little at 0.0660 on 7.3 million shares. The three month avg. volume is 4.9 million shares. This is not good, down on 7.3 million shares. We go lower with no good news.

AAPL closed down $8.07 at $577.67 on 11.6 million shares. The three month avg. volume is 20.8 million shares.

Oil down below $80 is a good thing for U.S.A. We will buy more I-Phones, ect.

Good luck in this rigged casino,

Waiting for Dec 2012 Geron

Geron was down a little at $1.46 Wed. on 445,300. The three month avg. volume is 647,059 shares. Waiting for the 4 Phase two trials that end in Dec. 2012. Need a deal on the stem cell property.

ACTC under 7 cent closed at 0.0670 on 6 million shares. The three month avg. volume is 4.9 million shares. Again waiting on more results on the Phase 1/2 trials. Needs a partner soon, running out of money. SEC lawsuit they want  $3 million in fines.

AAPL up a little closed at $585.74 on 12.8 million shares. Three month avg. volume is 20.8 million shares.

Good luck in this rigged casino.

Geron dramatic 2H 2012 ahead

Geron Corporation (GERN) appears to have a dramatic 2H 2012 ahead of it with its telomerase inhibitor, Imetelstat, having topline data being released for phase II trials in breast cancer and for multiple myeloma. Telomerase appears to be a good target for attacking cancer because most cancers have high levels of telomerase activity according to the company s website. Adding to the therapy's potential value in fighting cancer in an adjuvant setting with paclitaxel and/or bevacizumab for breast cancer and with/without lenalidomide for multiple myeloma, the drug is also in phase II trials for non-small cell lung cancer and Essential Thrombocythemia (ET) or Polycythemia Vera (PV). However, promising data in preclincals indicating efficacy in inhibiting cancer stem cells (CSC) growth in a broad range of tumors could turn into a huge catalyst in upcoming years. CSC's are thought to be responsible for the recurrent nature and metastasis of many cancers, and solid efficacy in advanced trials could prove to be a significant event as this indication is further investigated.
As important as Imetelstat can be for its currently targeted indications, the greater upside in the event of success in both efficacy and safety will be realized if the drug validates itself for any one of these indications. Success in one indication can mean real or perceived success in the many other cancers with elevated telomerase activity. The upside here can be significant, while the corresponding downside is also present as failure in a phase II trial could also mean real or perceived failure of the drug's efficacy/safety in most/all other indications.
Geron closed up 1 penny at $1.47 on 581,575 shares. The three month avg. volume is 651,383 shares. If Geron's  four Phase 2 trials results are good we should hit $5.00 if not 50 cents is possible.

ACTC under 7 cents not good. No news, we will go lower.

AAPL closed up at $587.41 it's the only stock I have in the green.

Good luck in this rigged casino,

AAPL and Geron up

AAPL is above my avg cost I'm in the green. AAPL closed at $588.78 up $11.85 on 15.7 million shares. The three month avg. volume 21.4 million shares. Still feel AAPL is the best company out there.

Geron closed up one penny at $1.41 on 444,438 shares. The three month avg. volume is 652,473 shares. Rumor is some thing big is going to happen soon with GE or ?. I think it's all wishful thinking. There is no price increase and no volume.

ACTC closed down at 0.0702 on 6.7 million shares. The three month avg. volume is 5.1 million shares. Waiting for the reverse split vote, waiting for the SEC lawsuit to be settled, waiting for more good Phase 1/2 results, waiting for a partner, waiting to be put on the big broad. This company is a big big gamble.

Good luck in this rigged casino,

Geron down after 5 up days

After 5 wonderful up days, Geron closed down 5 cents at $1.45, on 801,053 shares. The three month avg. volume is 662,494 shares. Hoping for good news soon. The patent lawsuit should be over this month.

ACTC closed a little at 0.0725 on 1.2 million shares. The three month avg volume is 5.2 million shares. Wait, wait, wait. The SEC lawsuit, Phase 1/2 trial results, a partner with deep pockets.

AAPL closed up a little at $574.12 on 11.9 million shares. The three month avg. volume is 22.5 million shares.

Monday's market will be interesting. Greece election will move the market.

Good luck in this rigged casino,

Geron up 5 days in a row

Geron closed up 5 cent at $1.50 on 631.935 shares. The three month avg. volume is 662,494 shares. Still need more volume. But up 5 days in a row is very good news in its self. Maybe some good news is coming.

ACTC up a little to close at 0.0739 on 3.3 million shares. Three month avg. volume is 5.2 million shares. Still a waiting game.

AAPL closed down 63 cent at $571.53 on 12.3 million shares. Not good on a up day and the best company out there closes down.

Good luck in this rigged casino,

Geron up 4 days in a row

From $1.28 on June 7th close, to $1.45 today June 13th. I see a trend [maybe] still need more volume. Patent lawsuit is entering the final phase. Outcome should move share price. After lawsuit, acquisition talks will start for real. Remember 4 Phase two results at the end of this year Dec. 2012 must have good results for Geron to stay alive as a company.

ACTC closed at 0.0720 on 2.5 million shares. Three month avg. volume 22.9 million shares. Wait, wait  and more waiting for Phase 1/2 trials.

AAPL closed at $572.16 down $4.00 on 10.5 million shares. Three month avg. volume is 22.9 million shares. Still the best company out there.

Good luck in this rigged casino,

Geron up again

Geron closed up 6 cent at $1.40 on 579,893 shares. The three month avg. volume is 665,688 shares. No real volume we need 2 million+,  then we will know [maybe] that some thing good is up. The patent case should be over soon, this month maybe.

ACTC was down just a little to close at 0.0740 on 1.2 million shares. The three month avg. volume is 5.5 million shares. Need good results from Phase 1/2 trials and a partner soon.

AAPL closed at $576.16 up a little on 15.2 million shares. The three month avg. volume is 22.9 million shares.

Good luck in this rigged casino,

Geron up on being added to Russell Microcap

Geron closed up 4 cents at $1.35 on 697,486 shares. Three month volume avg. is 667,139 shares. To double in price, the patent court ruling must go in Geron favor and a stem cell deal that gives Geron some cash.

ACTC closed at 0.0759 on 1.9 million shares. Three month avg. volume is 5.5 million shares. Wait, wait and wait some more for Phase 1/2 results

AAPL down $9.15 to closed at $571.17 on 21.1 million shares. Three month avg. volumes is 22.9 million shares.

Good luck in this rigged casino,

AAPL up after I sold a few shares

I sold 4 shares of AAPL today at $573.12 and up up up and away AAPL went. Needed some cash. I think I'm going to get fired. My boss wrote me up because she didn't like the way I said "Why?" Still laughing at that one. AAPL closed up $8.60 at $580.32 on 12.4 million shares. Three month avg. volume is 22.8 million shares.

ACTC closed up a little at 0.0759 on 1.7 million shares. The three month avg. volume is 5.5 million shares. Wait, wait and wait some more.

Geron closed up 3 cents at $1.31 on 408,341 shares. The three month avg. volume is 667,139 shares. Need news soon or it's down we go.

Good luck in this rigged casino,

Geron way oversold

Near term catalysts for Geron are: patent court clearance, partner offers that follow, updates on FDA trials and GERN trading near cash value of $120 million. GERN is way oversold here.
Remember you can lose all your money in any stock.

Good luck in this rigged casino,          

Geron going no where, ACTC down a little

Well Geron did hit its 52 week low of $1.25 and closed at $1.28 1.1 million. The three month volume avg is 674,617 shares.

ACTC down a little at 0.0740 on 2.2 million shares. Three month avg. volume is 5.6 million shares.

AAPL closed at  $571.72  up 0.26 on 13.6 million shares. The three month avg. volume is 23 million shares.

It's just wait and see what happens. Will Geron and ACTC find a partner. Will the trials have good results. If it's yes to all I'll be rich,  if no, it's work till I drop dead.

Good luck in this rigged casino,

ACTC closed up 12% Geron up on webcast

ACTC closed up 12.83% at 0.0765 on 5.2 million shares three month avg. volume is 5.7 million shares. Up on rumor China will partner up.

Geron: Buyers went wild and bet it up 1 whole penny off of webcast. I liked Chip's story, I think he's seeing good results from the Phase II trials. Listen to webcast when he says results on the 4 Phase II trials will be coming very soon. Geron closed up one penny at $1.31 on 634,882 shares, three month avg. volume is 678,256 shares.

AAPL went up closed at $571.46 closed to my avg cost. It still the best company out there.

Good luck in this rigged casino,

ACTC soaring Geron webcast good

ACTC is up 12% on 4 million shares. Rumor is China wants a piece of ACTC. I think that might happen but it will be down the road. Should ACTC Phase I/II trial on SMD and AMD retard vision loss and or resue vision, ACTC and Lanza will be so in demand the company will instantly become a extremely good  "mid-cap".

Geron webcast was more of the same but it was good, the 4 Phase II trial will have results at the end of Q4 2012 [Dec]. Chip's voice sounded excited when he said the results will be coming soon, I think the results will be good. If I'm wrong I'll be working till a drop dead.

AAPL up nice. It's still the best company out there.

Good luck in this rigged casino,

Geron webcast June 6 at 1:30PM

On Yahoo Message Broad people are hoping that Chip [Geron's CEO] will give us some good news. The patent lawsuit is entering the final phase, outcome should move share price [up or down]. If the patent lawsuit is settled, in Geron's  favor, acquisition talks will start for real. Geron close up 3 cents at $1.30 on 954,490 shares. The three month avg. volume is 678,256 shares. If we don't get any good news we will break the 52 week low again.

ACTC closed 0.0678 on 2.6 million shares, three month avg. volume is 5.7 million shares. No news and no real volume. With the SEC lawsuit, no partner, little money and no news we will head lower.

AAPL closed down $1.46 at $562.83 on 13.8 million shares, three month avg. volume is 23.5 million shares. Still feel AAPL is the best company out there.

Good luck is this rigged casino,

Geron Webcast June 6th 1PM

Geron's CEO Chip will present at Jefferies 2012 Global Healthcare Conference in New York City June 6th at 1PM ET live webcast. Most likely more of the same, but I hope there will be some good news to lift the stock price. Geron closed down one cent at $1.27 on 427,883 shares. Three month avg. volume 674,331 shares

ACTC down a little at 0.0678 on 5.8 million shares. Three month avg. volume is 5.8 million shares.

AAPL closed at $564.29 on 19.9 million shares. Three month avg. volume is 23.6.

We may bounce a little here, but I think the over all market is headed down. Save your money [if you have any left] prices will get cheaper.

Good luck in this rigged casino,

Geron GE where's the money?

Geron and GE
Screening new drugs with stem cells. Industry collaboration in the field was presented as essential; a collaboration with Geron proved to be critical in advancing GE Healthcare's toxicology work. "What we gained from Geron's is the ability to grow large quantities of cells on an industrial scale. One of the first products that we created in collabration with Geron was cardiomyocyte generation from h7hES cells. It ended up being a 28 , day process of selection with no genetic engineering.
The cost savings for drug development are substantial as stem cells can be used to expose drugs with dangerous side effects before they reach the market.
So while stem cells still hold great promise for regenerative medicine their use as tools  for research and drug testing is having more immediate impact.
Show me the money GE! When will Geron get more payments. Geron will not disclose details of payments if any. Geron hit a new 52 week low again at $1.25.

Good luck in this rigged casino,

Down we go AAPL ACTC Geron

Fear is in the market. Down, down down we will go.
AAPL down $16.75 to close at $560.99.
Geron a new 52 week low again at $1.25, closed at $1.28. With no news on the trials till the end of Dec 2012, only two things can move this up, the Viacyte case is settled in Geron's favor, and a stem cell partnership or sale is made. With no news it's down down down.
ACTC down a little at 0.0685. The civil suit is for $3.5 million. This one will go down until the Phase 1/2 trial results are in.

Good luck in this rigged casino,

Down We Go

With the poor job numbers the market will sell off. Maybe a bounce at the end of the day. Buy stocks with great balance sheets and that pay a dividend [at least 2%] Geron, ACTC and even AAPL will be down big.


Good luck in this rigged casino,